Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge

Journal Title: Women's Health Science Journal - Year 2022, Vol 6, Issue 2

Abstract

Background: Monoclonal antibody (mAb) therapy has been recommended in non-hospitalized COVID-19 positive pregnant individuals with mild to moderate symptoms despite data on safety and efficacy. Objective: To assess short-term outcomes of mAb treatment in COVID-19 positive pregnant patients during the Omicron surge. Methods: This is a descriptive study of pregnant patients receiving mAb therapy from December 1, 2021, and March 18, 2022 during the Omicron surge. Patients received either (1) sotrovimab, or (2) bamlanivimab/etesivimab, or (3) casirivimab / imdevimab. We reviewed the medical records of pregnant patients who received mAb, gathering baseline demographics and assessing adverse events from mAb infusion. Results: Twenty-one pregnant patients received mAbs during the Omicron surge. The short-term maternal outcomes for most of our cohort were favorable. One patient developed an anaphylactic reaction following infusion of bamlanivimab/etesevimab. One patient required admission to the intermediate care unit for severe COVID-19 fifteen days following infusion, and a second patient developed cardiorespiratory symptoms concerning for post-acute sequelae SARS-CoV-2 infection. Adverse pregnancy outcomes were present in 43.7% of our delivered cohort (n=16). Conclusion: Short-term outcomes in pregnant patients who received monoclonal antibodies for COVID-19 during the Omicron surge are mostly favorable, with symptom resolution and rare adverse events.

Authors and Affiliations

Loza AJ*, Farias RD, Gavin NR, Wagner RK and Shields AD

Keywords

Related Articles

The Availability and Effectiveness of Lactation Rooms Usage in Shopping Centers (Case Study in Metropolitan Jakarta)

Backgrounds: World Health Assembly stated that 41% of infants less than 6 months are exclusively breastfed, whereas the global rate target is at least 50% by 2025. Indonesia’s rate of exclusive breastfeeding was 68.7% in...

The Psychobehavioral Responses of Pregnant Women towards the COVID-19 Pandemic

Psychological distress during pregnancy can have adverse effects on both maternal and fetal wellbeing. It is a well-known fact that it increases risk of preterm deliveries and low birth weight babies. The objective of th...

“Oral Menopause” - Do you know this Phenomenon?

Patients as well as therapists, even dental professionals, are not fully aware of the fact that menopausal oral problems can seriously impair quality of life. However, hormone receptors in the oral mucosa may cause dry m...

Women’s Psychological Health During the COVID-19 Pandemic

As coronavirus disease 19 (COVID-19) has continued to impact societies for more than one year, everyone has been influenced by the negative impact of COVID-19 [1,2]. Patterns of daily life have considerably changed. Addi...

Successful Distance-based Training for Technologically Challenged Urban HIV Providers

The Howard University College of Medicine implemented the AIDS Education and Training Center (AETC) Telehealth Training Center (HU-AETC TTC) was funded to use telehealth technologies to provide training and support to lo...

Download PDF file
  • EP ID EP746538
  • DOI 10.23880/whsj-16000167
  • Views 15
  • Downloads 0

How To Cite

Loza AJ*, Farias RD, Gavin NR, Wagner RK and Shields AD (2022). Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge. Women's Health Science Journal, 6(2), -. https://europub.co.uk/articles/-A-746538